Infectious Disorder Of Joint — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infectious disorder of joint. 17 active patents protecting 3 drugs from 3+ originators. First major cliff: 2035. Daily refresh.

3
Approved drugs
17
Active US patents
55/100
Avg vulnerability
—
Annual revenue covered

Originators in Infectious Disorder Of Joint

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Baxter 9 patents ANI Pharmaceuticals 5 patents Pfizer 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infectious disorder of joint. Each bar = one year. Y-axis scaled to peak year (5 patents).

1
26
3
28
4
32
5
35
2
36
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02
Vancocin
vancomycin
 ANI Pharmaceuticals 5 39 — 2035-11-06
Cleocin T
CLINDAMYCIN PHOSPHATE
 Pfizer 3 68 — 2026-12-02

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9789057 Cleocin T method of use 80 2026-12-02
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
11129896 Cleocin T method of use 70 2036-09-22
8946276 Metro I.V. In Plastic Container method of use 62 2032-06-28
9198858 Metro I.V. In Plastic Container method of use 62 2032-06-28
8877792 Metro I.V. In Plastic Container formulation 55 2028-02-02
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19
12303563 Cleocin T formulation 55 2036-09-22
11517609 Vancocin method of use 53 2035-11-06

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11000567 Vancocin formulation 25 2035-11-06
10849956 Vancocin formulation 25 2035-11-06
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10188697 Vancocin method of use 45 2035-11-06
10039804 Vancocin method of use 45 2035-11-06
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04
11517609 Vancocin method of use 53 2035-11-06
12303563 Cleocin T formulation 55 2036-09-22
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19

Related